ONPH — Oncology Pharma Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.04m
- $0.64m
- $0.01m
Annual cashflow statement for Oncology Pharma, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2002 March 31st | 2003 March 31st | 2004 March 31st | 2011 June 30th | 2013 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | — | 12 M |
| Source: | 10KSB | 10KSB | 10KSB | ARS | |
| Standards: | USG | USG | USG | — | — |
| Status: | Final | Final | Final | fx Preliminary | Final |
| Net Income/Starting Line | -1.95 | -1.52 | -1.56 | — | -0.186 |
| Depreciation | |||||
| Non-Cash Items | 0.004 | 0.037 | -0.135 | — | 0 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.156 | -0.356 | -0.381 | — | 0.185 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -1.45 | -1.44 | -2 | — | -0.007 |
| Capital Expenditures | -0.323 | -0.147 | -0.017 | — | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0.002 | 0.133 | — | -0.186 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.323 | -0.145 | 0.116 | — | -0.186 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.633 | 0.001 | 0.546 | — | 0.206 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.14 | -1.59 | -1.34 | — | 0.012 |